Related Experiment Video
Updated: Apr 15, 2026
10:31
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
843
Lipidomics: new insight into kidney disease
Ying-Yong Zhao1, Nosratola D Vaziri2, Rui-Chao Lin3
1Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, The College of Life Sciences, Northwest University, Xi'an, Shaanxi, PR China; Division of Nephrology and Hypertension, School of Medicine, University of California, Irvine, California, USA.
Advances in Clinical Chemistry
|April 11, 2015
Summary
Chronic kidney disease (CKD) poses a global health challenge. Lipidomics offers promising new biomarkers for early CKD detection and management, improving patient outcomes.
Area of Science:
- Biochemistry
- Metabolomics
- Nephrology
Background:
- Chronic kidney disease (CKD) is a significant global health issue, often linked to diabetes and hypertension.
- CKD leads to premature death via cardiovascular disease and other complications.
- Current renal function biomarkers lack sensitivity for early disease detection, hindering timely intervention.
Purpose of the Study:
- To review advancements in lipidomics for kidney disease research.
- To highlight the role of lipid metabolism in CKD progression and complications.
- To discuss lipidomics applications in diagnosing and managing various kidney diseases.
Main Methods:
- Comprehensive review of clinical and experimental research on lipidomics in kidney diseases.
- Analysis of lipidomics analytical technologies and data interpretation methods.
- Identification and discussion of known lipid metabolic biomarkers for kidney diseases.
Main Results:
- Lipidomics enables global study of lipids and their functions in health and disease.
- Profound alterations in lipid metabolism are observed in CKD, contributing to disease progression.
- Lipidomics aids in identifying biomarkers for diagnosis, prognosis, and therapeutic response in kidney diseases.
Conclusions:
- Lipidomics presents a powerful approach for early diagnosis and monitoring of kidney diseases.
- Understanding lipid alterations is crucial for managing CKD and its cardiovascular risks.
- Further research into lipidomics holds potential for improved therapeutic strategies in nephrology.
Related Concept Videos
01:21External Anatomy of the Kidney
5.0K
The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
5.0K
01:24Nephrotic Syndrome I : Introduction
1.1K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.1K
01:24Chronic Kidney Disease II: Clinical Manifestations
1.0K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.0K
01:26Nephrotic Syndrome II : Assessment and Medical Management
360
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
360
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
306
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
306
01:25Chronic Kidney Disease I: Introduction
1.2K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K